Literature DB >> 8454910

Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster.

D Choubey1, P Lengyel.   

Abstract

Recently, we reported that an interferon (IFN)-inducible, murine 72-kD phosphoprotein (the 204 protein) that is encoded by the Ifi 204 gene from the gene 200 cluster is localized in the nucleolus and the nucleoplasm. We have now raised a polyclonal antiserum against the 202 protein that is encoded by the Ifi 202 gene from the same gene cluster and regions of which are homologous to those from the 204 protein. Using the antiserum, we established that the 202 protein is a 52-kD phosphoprotein whose level in cells from various murine lines can be increased up to 16-fold upon treatment with IFN-alpha. Experiments involving fractionation of cell lysates and indirect immunofluorescence microscopy of cultured cells revealed that the 202 protein was localized in the cytoplasm and the nucleus. Upon treatment of cells with IFN, the 202 protein first accumulated on the surface of a cytoplasmic, membranous fraction and after prolonged treatment with IFN it was localized mainly in the nucleus. In IFN-treated mitotic AKR cells, the 202 protein was colocalized with chromosomes. 202 protein extracted from IFN-treated AKR cells bound double-stranded DNA in vitro. Studies on 202 protein function should be facilitated by the availability of complete cDNA clones and the finding of cell lines and an inbred strain of mice in which the expression of this protein was impaired.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454910     DOI: 10.1089/jir.1993.13.43

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  30 in total

Review 1.  Transcription and growth regulatory functions of the HIN-200 family of proteins.

Authors:  R W Johnstone; J A Trapani
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription.

Authors:  C J Liu; H Wang; P Lengyel
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

Review 4.  Interferon-inducible Ifi200-family genes in systemic lupus erythematosus.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Immunol Lett       Date:  2008-07-01       Impact factor: 3.685

5.  Inhibition of E2F-mediated transcription by p202.

Authors:  D Choubey; S J Li; B Datta; J U Gutterman; P Lengyel
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

6.  Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE.

Authors:  Ravichandran Panchanathan; Xin Duan; Muthuvel Arumugam; Hui Shen; Hongzhu Liu; Divaker Choubey
Journal:  Mol Immunol       Date:  2011-09-23       Impact factor: 4.407

Review 7.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

Review 8.  Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins.

Authors:  Sudhakar Veeranki; Divaker Choubey
Journal:  Immunol Lett       Date:  2010-06-26       Impact factor: 3.685

Review 9.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

10.  IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.

Authors:  Mary Zimmerman; Dafeng Yang; Xiaolin Hu; Feiyan Liu; Nagendra Singh; Darren Browning; Vadivel Ganapathy; Phillip Chandler; Divaker Choubey; Scott I Abrams; Kebin Liu
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.